Latin America News Q3 2018

14 LATIN AMERICA NEWS / Q3 2018 , Revolutionary New Offering To Support Argentinean Farming Industry Verdeca Introduces Drought Tolerant Soybeans in Argentina- the firm’s HB4® soybean trait to help growers overcome challenging climate conditions. Arcadia Biosciences, Inc. and Bioceres S.A., through their joint venture Verdeca, have announced the introduction of soybeans that deliver compelling yield increases under drought conditions. At this week’s APPRESID Congress, being held in Cordoba, Argentina, August 8-10, Verdeca is presenting the HB4 technology to producers. The event targets innovative soybean growers who will be invited to participate in future pre-commercial testing. The introduction marks the first step in commercializing the HB4 trait, which is the result of multiple years of research and development, both in Argentina and the U.S. The trait is Verdeca’s first release from a pipeline of traits expected to benefit soybean producers and demonstrates the company’s ability to deliver on its commitment to bringing innovation to aid soybean producers through quality improvement or stress mitigation. “HB4 technology will give growers a unique tool to help combat the challenges of managing climate variability,” said Federico Trucco, CEO of Bioceres. “Field trials conducted in the difficult drought conditions faced by Argentina’s farmers in 2018 further validated this belief.” Soybeans are the world’s fourth largest crop, grown on more than 120 million hectares annually. Global population growth, combined with a growing middle class in countries like China and India, have resulted in increased demand for this important protein source. More than 50 million of the world’s soybean hectares are grown in Argentina and Brazil, a region that has experienced significant drought conditions in recent years. “Positive results of our HB4 technology have been demonstrated in numerous field trials in major soybean production areas in South America and the U.S.,” said Raj Ketkar, president and CEO of Arcadia Biosciences. “The technology is currently being bred into elite soybean varieties by Verdeca’s seed company partners, and we are preparing for the commercial launch of HB4 in 2019, pending regulatory approval in China.” Arcadia and Bioceres formed Verdeca in 2012 to deploy next-generation soybean traits in all key production regions, beginning in South America and North America, which together represent nearly 80 percent of the harvested soybean acres globally. Verdeca’s HB4 trait has already been approved in Argentina and by the U.S. Food & Drug Administration. Regulatory submissions are currently under consideration by the U.S. Department of Agriculture and in Brazil and China.